MagnaChip Collaborates with Massachusetts General Hospital and Pohang University of Science and Technology on Magnetic Bio-Sensor Development
Based on its industry-leading 0.18 micron mixed-signal technology, MagnaChip is looking to extend high performance silicon magnetic sensor technology beyond current commercial applications. In collaboration with leading researchers, MagnaChip is focused on developing a novel bio-sensor platform that can enhance medical technology through cost-effective disease detection. "This joint development project will focus on early detection methods that leverage on advanced bio-sensor technologies thereby increasing the efficacy of research success," said Prof.
"We are very proud to be working with some of the world's best bio-sensor research teams. As a partner in this joint research, MagnaChip will apply its newly developed 0.18 micron silicon magnetic sensor technology to create single-chip sensor solutions. This will enhance performance and lower the cost of medical diagnosis and monitoring," said YJ Kim, MagnaChip interim CEO.
About
Headquartered in
|
CONTACTS: |
|
|
In the United States: Robert Pursel Director of Investor Relations Tel. +1-408-625-1262 |
In Korea: Chankeun Park Senior Manager, Public Relations Tel. +82-2-6903-3195 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/magnachip-collaborates-with-massachusetts-general-hospital-and-pohang-university-of-science-and-technology-on-magnetic-bio-sensor-development-300013937.html |
SOURCE